期刊文献+

降同型半胱氨酸治疗对冠心病介入术后患者炎性因子水平的疗效观察 被引量:3

下载PDF
导出
摘要 目的探究将降同型半胱氨酸疗法应用于冠心病介入术治疗中的效果。方法选择我院中2017年4月至2017年10月间收治的冠心病介入治疗患者76例作为研究对象,通过随机分组方案,将所有患者分为对照组和实验组,每组中均包含38例患者,对照组患者采用单纯介入手术方案进行治疗,实验组患者在此基础上加用降同型半胱氨酸疗法作为治疗方案,对比两组患者的炎性因子水平。结果实验结果显示,实验组患者的CRP、IL-6以及IL-8指标较对照组明显更优,且差异具有统计学意义(P<0.05)。结论将降同型半胱氨酸疗法应用于冠心病患者的介入治疗中,能够有效辅助治疗工作的开展,对于患者的康复有十分积极的意义,值得推广使用。
作者 刘明
出处 《心血管病防治知识(学术版)》 2018年第8期20-22,共3页 Prevention and Treatment of Cardiovascular Disease
  • 相关文献

参考文献2

二级参考文献19

  • 1Shenoy V, Mehendale V, Prabhu K, et al. Correlation of ser- um homocysteine levels with the severity of coronary artery dis- ease [J]. Indian JClinBiochem, 2014, 29 (3): 339-344.
  • 2Schaffer A, Verdoia M, Cassetti E, et al. Relationship be- tween homocysteine and coronary artery disease. Results from a large prospective cohort study [J]. Thromb Res, 2014, 134 (2): 288-293.
  • 3Basati G, Razavi AlE, Abdi S, et al. Association of plasma lep- tin, homocysteine and nitric oxide levels with the presence and unstability of coronary artery disease E J. Biomark Med,2014, 8 (3): 405-412.
  • 4Saffari B, Senemar S, Karimi M, et al. An MTHFR variant, plasma homocysteine levels and late- onset coronary artery dis- ease in subjects from southern Iran [J]. Pak J Biol Sci, 2013, 16 (16): 788-795.
  • 5Mehlig K, Leander K, de Faire U, et al. The association be- tween plasma homocysteine and coronary heart disease is modi- fied by the MTHFR 677C&gt T polymorphism [J]. Heart, 2013, 99 (23).. 1761-1765.
  • 6van Meurs JB, Pare G, Schwartz SM, et al. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease [J]. Am J Clin Nutr, 2013, 98 (3): 668-676.
  • 7Karolczak K, Kamysz W, Karafova A, et al. Homocysteine is a novel risk factor for suboptimal response of blood patelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study [J]. Pharmacol Res, 2013, 74: 7-22.
  • 8Naghshtabrizi B, Shakerian F, Hajilooi M, et al. Plasma ho- mocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography [J]. JCardiovascDisRes, 2012, 3 (4) 276-279.
  • 9Chalghoum A, Noichri Y, Chkioua L, et al. Metabolic inter- actions between the hyperhomocysteinemia and angiotensin - 1 converting enzyme activity in Tunisian patients with coronary heart disease [J]. Ann Biol Clin (Paris), 2012, 70 (5): 599 - 604.
  • 10Igland J, Vollset SE, Nyggrd OK, et al. Relative importance of risk factors for coronary heart disease- - the Hordaland Ho- mocysteine study [J]. Scand Cardiovasc J, 2012, 46 (6): 316 - 323.

共引文献11

同被引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部